Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis. (Q38883295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

0 references

Harriet Mayanja-Kizza

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Jerrold Ellner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

John L Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Emmanuel Ssekasanvu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Alphonse Okwera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Christina S Hirsch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Joseph G Nakibali

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Dana Drzayich Jankus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Kathleen D Eisenach

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W Henry Boom

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Roy D Mugerwa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Uganda-Case Western Reserve University Research Collaboration

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

17 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

185-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702550%20AND%20SRC:MED&resulttype=core&format=json

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC

Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC

Administration of recombinant interleukin-2 reduces the local parasite load of patients with disseminated cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC

The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC

The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC

The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC

Guidelines for conducting tuberculin skin test surveys in high prevalence countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC

CD8+ T cells in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC

Human dendritic cells presenting adenovirally expressed antigen elicit Mycobacterium tuberculosis--specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1359OC